Cargando…

Lactoferrin-Conjugated Nanoparticles as New Antivirals

Lactoferrin is an iron-binding glycoprotein with multiple functions in the body. Its activity against a broad spectrum of both DNA and RNA viruses as well as the ability to modulate immune responses have made it of interest in the pharmaceutical and food industries. The mechanisms of its antiviral a...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzyzowska, Malgorzata, Janicka, Martyna, Tomaszewska, Emilia, Ranoszek-Soliwoda, Katarzyna, Celichowski, Grzegorz, Grobelny, Jarosław, Szymanski, Pawel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504495/
https://www.ncbi.nlm.nih.gov/pubmed/36145610
http://dx.doi.org/10.3390/pharmaceutics14091862
_version_ 1784796231238680576
author Krzyzowska, Malgorzata
Janicka, Martyna
Tomaszewska, Emilia
Ranoszek-Soliwoda, Katarzyna
Celichowski, Grzegorz
Grobelny, Jarosław
Szymanski, Pawel
author_facet Krzyzowska, Malgorzata
Janicka, Martyna
Tomaszewska, Emilia
Ranoszek-Soliwoda, Katarzyna
Celichowski, Grzegorz
Grobelny, Jarosław
Szymanski, Pawel
author_sort Krzyzowska, Malgorzata
collection PubMed
description Lactoferrin is an iron-binding glycoprotein with multiple functions in the body. Its activity against a broad spectrum of both DNA and RNA viruses as well as the ability to modulate immune responses have made it of interest in the pharmaceutical and food industries. The mechanisms of its antiviral activity include direct binding to the viruses or its receptors or the upregulation of antiviral responses by the immune system. Recently, much effort has been devoted to the use of nanotechnology in the development of new antivirals. In this review, we focus on describing the antiviral mechanisms of lactoferrin and the possible use of nanotechnology to construct safe and effective new antiviral drugs.
format Online
Article
Text
id pubmed-9504495
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95044952022-09-24 Lactoferrin-Conjugated Nanoparticles as New Antivirals Krzyzowska, Malgorzata Janicka, Martyna Tomaszewska, Emilia Ranoszek-Soliwoda, Katarzyna Celichowski, Grzegorz Grobelny, Jarosław Szymanski, Pawel Pharmaceutics Review Lactoferrin is an iron-binding glycoprotein with multiple functions in the body. Its activity against a broad spectrum of both DNA and RNA viruses as well as the ability to modulate immune responses have made it of interest in the pharmaceutical and food industries. The mechanisms of its antiviral activity include direct binding to the viruses or its receptors or the upregulation of antiviral responses by the immune system. Recently, much effort has been devoted to the use of nanotechnology in the development of new antivirals. In this review, we focus on describing the antiviral mechanisms of lactoferrin and the possible use of nanotechnology to construct safe and effective new antiviral drugs. MDPI 2022-09-03 /pmc/articles/PMC9504495/ /pubmed/36145610 http://dx.doi.org/10.3390/pharmaceutics14091862 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Krzyzowska, Malgorzata
Janicka, Martyna
Tomaszewska, Emilia
Ranoszek-Soliwoda, Katarzyna
Celichowski, Grzegorz
Grobelny, Jarosław
Szymanski, Pawel
Lactoferrin-Conjugated Nanoparticles as New Antivirals
title Lactoferrin-Conjugated Nanoparticles as New Antivirals
title_full Lactoferrin-Conjugated Nanoparticles as New Antivirals
title_fullStr Lactoferrin-Conjugated Nanoparticles as New Antivirals
title_full_unstemmed Lactoferrin-Conjugated Nanoparticles as New Antivirals
title_short Lactoferrin-Conjugated Nanoparticles as New Antivirals
title_sort lactoferrin-conjugated nanoparticles as new antivirals
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504495/
https://www.ncbi.nlm.nih.gov/pubmed/36145610
http://dx.doi.org/10.3390/pharmaceutics14091862
work_keys_str_mv AT krzyzowskamalgorzata lactoferrinconjugatednanoparticlesasnewantivirals
AT janickamartyna lactoferrinconjugatednanoparticlesasnewantivirals
AT tomaszewskaemilia lactoferrinconjugatednanoparticlesasnewantivirals
AT ranoszeksoliwodakatarzyna lactoferrinconjugatednanoparticlesasnewantivirals
AT celichowskigrzegorz lactoferrinconjugatednanoparticlesasnewantivirals
AT grobelnyjarosław lactoferrinconjugatednanoparticlesasnewantivirals
AT szymanskipawel lactoferrinconjugatednanoparticlesasnewantivirals